$Safety of besifloxacin ophthalmic suspension 0.6% in refractive surgery: a retrospective chart review of post-LASIK patients$
QR Code

QR Code

Safety of besifloxacin ophthalmic suspension 0.6% in refractive surgery: a retrospective chart review of post-LASIK patients

Afficher d'autres versions (1)

Steven A Nielsen,1 Marguerite B McDonald,2 Parag A Majmudar31Nielsen Eye Center, Quincy, MA, USA; 2Ophthalmic Consultants of Long Island, Lynbrook, NY, USA; 3Chicago Cornea Consultants Hoffman Estates, IL, USABackground: To evaluate the safety of besifloxacin ophthalmic suspension 0.6% when used in...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Nielsen SA, McDonald MB, Majmudar PA
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2013
Sujets:	Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/d6b4bbe8a6784bbd8e8d01cbb62b490b
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Safety of besifloxacin ophthalmic suspension 0.6% in refractive surgery: a retrospective chart review of post-LASIK patients
par: Nielsen SA, et autres
Publié: (2013)

Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis patients with Pseudomonas aeruginosa infections
par: Silverstein BE, et autres
Publié: (2012)

Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes
par: Morris TW, et autres
Publié: (2011)

Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: etiology of bacterial conjunctivitis and antibacterial susceptibility profile
par: Haas W, et autres
Publié: (2011)

Characterization of Polybacterial versus Monobacterial Conjunctivitis Infections in Pediatric Subjects Across Multiple Studies and Microbiological Outcomes with Besifloxacin Ophthalmic Suspension 0.6%
par: Blondeau JM, et autres
Publié: (2021)

Safety of besifloxacin ophthalmic suspension 0.6% as a prophylactic antibiotic following routine cataract surgery: results of a prospective, parallel-group, investigator-masked study
par: Malhotra R, et autres
Publié: (2012)

Antibacterial efficacy of prophylactic besifloxacin 0.6% and moxifloxacin 0.5% in patients undergoing cataract surgery
par: Bucci FA Jr, et autres
Publié: (2015)

A retrospective analysis of the use of loteprednol etabonate ophthalmic suspension 0.5% following canaloplasty
par: Khaimi MA
Publié: (2018)

Contribution of the R8 substituent to the in vitro antibacterial potency of besifloxacin and comparator ophthalmic fluoroquinolones
par: Haas W, et autres
Publié: (2013)

Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK
par: Wang XJ, et autres
Publié: (2011)

Dose uniformity of loteprednol etabonate ophthalmic gel (0.5%) compared with branded and generic prednisolone acetate ophthalmic suspension (1%)
par: Marlowe ZT, et autres
Publié: (2013)

Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension
par: Bruce I Gaynes, et autres
Publié: (2008)

Dose uniformity of topical corticosteroid preparations: difluprednate ophthalmic emulsion 0.05% versus branded and generic prednisolone acetate ophthalmic suspension 1%
par: William Stringer, et autres
Publié: (2010)

Predictability and stability of refraction with increasing optical zone diameter in hyperopic LASIK
par: Mostafa A El-Helw, et autres
Publié: (2010)

Refractive outcomes of an advanced aspherically optimized profile for myopia corrections by LASIK: a retrospective comparison with the standard aspherically optimized profile
par: Meyer B, et autres
Publié: (2015)

Topography-modified refraction: adjustment of treated cylinder amount and axis to the topography versus standard clinical refraction in myopic topography-guided LASIK
par: Alpins N
Publié: (2017)

Evaluation of dacryocystorhinostomy using optical coherence tomography and rebamipide ophthalmic suspension
par: Fujimoto M, et autres
Publié: (2014)

Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye
par: Deveney T, et autres
Publié: (2018)

Topography-modified refraction (TMR): adjustment of treated cylinder amount and axis to the topography versus standard clinical refraction in myopic topography-guided LASIK
par: Kanellopoulos AJ
Publié: (2016)

Efficacy of nepafenac ophthalmic suspension 0.1% in improving clinical outcomes following cataract surgery in patients with diabetes: an analysis of two randomized studies
par: Singh RP, et autres
Publié: (2017)

Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal
par: Kashima T, et autres
Publié: (2014)

The Prospective Health Assessment of Cataract Patients’ Ocular Surface (PHACO) study: the effect of dry eye
par: Trattler WB, et autres
Publié: (2017)

Comparative study of FS-LASIK and FS-LASIK combined with accelerated corneal cross-linking for correction of high myopia in the early stage of refractive power and corneal high-order aberration
par: Wen-Jia Cao, et autres
Publié: (2021)

Besifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitis
par: Timothy L Comstock, et autres
Publié: (2010)

Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial
par: Nichols KK, et autres
Publié: (2018)

Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease
par: Burade V, et autres
Publié: (2020)

Comparison of visual acuity, refractive outcomes, and satisfaction between LASIK performed with a microkeratome and a femto laser
par: Hashmani S, et autres
Publié: (2017)

ELECTRICAL BEHAVIOR OF A Cu2Fe0.4Co0.6SnS4 CERAMIC
par: LÓPEZ-VERGARA,FERNANDA, et autres
Publié: (2013)

Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum]
par: Nichols KK, et autres
Publié: (2018)

Vector Analysis Reveals That Topography-Guided LASIK Targeting the Manifest Refraction (MR) is Superior to Topography-Modified Refraction (TMR) and Layer Yolked Reduction of Astigmatism (LYRA) [Letter]
par: Wallerstein A, et autres
Publié: (2021)

A randomized controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for acute viral conjunctivitis
par: Pepose JS, et autres
Publié: (2019)

Control-matched comparison of refractive and visual outcomes between small incision lenticule extraction and femtosecond laser-assisted LASIK
par: Kataoka T, et autres
Publié: (2018)

Long-term bladeless LASIK outcomes with the FS200 Femtosecond and EX500 Excimer Laser workstation: the Refractive Suite
par: Kanellopoulos AJ, et autres
Publié: (2013)

Vector Analysis Reveals That Topography-Guided LASIK Targeting the Manifest Refraction (MR) is Superior to Topography-Modified Refraction (TMR) and Layer Yolked Reduction of Astigmatism (LYRA) [Response to Letter]
par: Aboalazayem F, et autres
Publié: (2021)

Evolution of the intrinsic electronic phase separation in La0.6Er0.1Sr0.3MnO3 perovskite
par: Lili Chen, et autres
Publié: (2016)

Early access to physiotherapy for infants with cerebral palsy: A retrospective chart review.
par: Linnéa Hekne, et autres
Publié: (2021)

Treatment patterns in diabetic macular edema in Taiwan: a retrospective chart review
par: Sheu SJ, et autres
Publié: (2018)

Rapid infusion of esketamine for unipolar and bipolar depression: a retrospective chart review
par: Correia-Melo FS, et autres
Publié: (2017)

Biomechanical Changes to the Cornea from LASIK Flap Creation Resulting in Inaccurate Ablations and Suboptimal Refractive Outcomes with Topographic-Guided Ablation
par: Motwani M
Publié: (2020)

Concentrations of besifloxacin, gatifloxacin, and moxifloxacin in human conjunctiva after topical ocular administration
par: Gail Torkildsen, et autres
Publié: (2010)